Correlation between changes in visual acuity and time in age-related macular degeneration

REAL J.P; PALMA SD; GRAMAJO L; JUAREZ CP; LUNA J.D

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Lugar: Rockville, MD 20852; Año: 2014 vol. 55 p. 602 - 602

0146-0404

Purpose Observe changes in visual acuity (VA) over time in patients with age related macular degeneration (AMD) from clinical diagnosis to first antiangiogenics treatment and after antiangiogenic loading doses to disease reactivation Methods A retrospective observational study was conducted. Patients with untreated wet ARMD, confirmed by fluorescein angiogram (FA) or optical coherence tomography (OCT) and a best corrected visual acuity (BCVA) of 20/40 to 20/320.The main outcome measures used were: the different delay times produced between indication for treatment (after initial and recurrence diagnosis) and intravitreal injection (initiation of loading dose and treatment dose for recurrence) with changes in BCVA produced along of this waiting time (WT). Results Eighty-Four eyes were included. The mean duration of initial WT was 87.5 days, the mean follow-up period was 1.81 years and 35% of patient had lost of VA compatible with recurrence criteria. Both WTs were significantly correla